The 14-3-3 protein family is known to interact with various proteins involved in signaling pathways. We report here the expression pattern of the Drosophila 14-3-3 (d14-3-3e) protein during embryonic development. In syncytial blastoderm when the nuclei divided rapidly, d14-3-3e localized in the nuclei. During cellularization d14-3-3e gradually became membrane-bound. During gastrulation, an enhanced staining in the perinuclear region was observed in various tissues. Co-labeling with dp-ERK which recognized the activated form of MAPK suggested that d14-3-3e was expressed prior to MAPK activation. During neuronal differentiation, the d14-3-3e protein remained at a high level in the neuronal cytoplasm.
Results
The 14-3-3 proteins are highly conserved and are involved in a variety of cellular processes (Marais and Marshall, 1995; Aitken, 1996) . In Drosophila two isoforms of the 14-3-3 proteins, e and z, are involved in receptor tyrosine kinase (RTK) mediated signaling pathways. The e isoform functions in the Sevenless pathway required for R7 photoreceptor formation (Chang and Rubin, 1997) . The z isoform is involved in the Torso pathway required for terminal system development in the embryos (Li et al., 1997) and in the Egfr pathway required for cell fate specification in the developing eyes (Kockel et al., 1997) . The z isoform is also required for the process of olfactory learning and memory which is mediated by an unknown signaling mechanism (Skoulakis and Davis, 1996) .
In western analysis, d14-3-3e was expressed as a 30 kDa protein in embryo extract (Fig. 1a) . Embryo staining revealed that d14-3-3e was expressed in a complicated pattern. At the onset of gastrulation, the expression pattern was missing in d14-3-3e mutant embryos (Fig. 1b,c) .
Expression in the syncytial and cellular blastoderm
In the syncytial embryos, d14-3-3e located exclusively and distributed evenly in the rapidly dividing nuclei (Fig.  2a,b) . During mitosis when the nuclear membrane partially broke down, the staining appeared as spindle-shape, suggesting that the protein was retained in the nuclei (Fig.  2c,d ). When cellularization occurred, the nuclear expression gradually diminished and membrane expression appeared (Fig. 2e) . When the cellularization process was completed, only the membrane staining was detected (Fig. 2f ).
Expression during gastrulation
During gastrulation, a low level of d14-3-3e membrane staining was observed in ectodermal cells Fig. 3a,b) ; however, a high level was transiently expressed in various tissues. At stage 7 and 8, this expression existed in several invaginating furrows (Fig. 3a) , the ventral midline cells (Fig. 3b) , and the dorsal epidermal cells (Fig. 3c) . At stage 9 and 10, prominent staining was observed in the ventral neurogenic region (Fig. 3d) , extending four-to five-cell wide from the midline. Interestingly, the staining in these tissues appeared in the perinuclear region of these (Fig. 3e) . These patterns are reminiscent of the dp-ERK staining that represents MAPK activation in vivo (Gabay et al., 1997a,b) . Co-labeling of d14-3-3e and dp-ERK showed that d14-3-3e was expressed prior to MAPK activation in these cells (Fig. 3f-h ). For example, at stage 8 when d14-3-3e was expressed in the ventral midline cells, dp-ERK was detected in the most posterior tip of the germ band (Fig. 3g) . At stage 9 when 14-3-3e was no longer detected in the midline cells, dp-ERK was expressed at a high level (Fig. 3h ).
Expression in the neurons
We observed that the d14-3-3e protein was highly enriched in the central and peripheral nervous systems (Fig.  4a-c) during neuronal differentiation. When co-labeled with anti-elav antibody that stains all neuronal nuclei, d14-3-3e was observed in the cytoplasm (Fig. 4d-f ). The accumulation of high levels of d14-3-3e may be due to continuous protein synthesis in the neurons since d14-3-3e mRNA was detected specifically in the CNS and PNS at these stages (data not shown).
The localization of d14-3-3e in different subcellular compartments may suggest that it is involved in different cellular processes during embryonic development. The peri-nuclear staining in cells prior to MAPK activation suggests that d14-3-3e may be involved in the MAPK signaling pathways. Consistently, the two Drosophila d14-3-3 proteins has been shown to be required for the Egfr, Sevenless and Torso signaling pathways (Chang and Rubin, 1997; Kockel et al., 1997; Li et al., 1997) . (f-h) Co-labeling of dp-ERK (in green) and d14-3-3e (in red) in posterior tip of germ band at stage 7 (f) and midline cells at stage 8 (g) and 9 (h). Midline cells are enclosed with the brackets. Notice the non-overlapping expressions of dp-ERK and d14-3-3e. Cells with both expressions are marked with arrows.
Methods
His-tagged d14-3-3e fusion protein was overexpressed in the BL21(DE3) bacteria and purified through a nickel column. Rabbit antisera were generated with the purified protein and were purified through affinity columns.
Wild type embryos were used for observation of the expression pattern. The Df(3R)p14 chromosome deletes d14-3-3e locus. About one quarter of Df(3R)p14/ + embryos missing the d14-3-3e staining after stage 8. For immunostaining, proper stages of embryos were fixed in 5% formaldehyde and washed several times with PBSTween (0.1%) solution before antibody staining. The primary antibodies used were rabbit anti-d14-3-3e (1/1000), mouse anti-dp-ERK (M8159, 1:250; Sigma), and rat antiElav (9F8A9, 1:250; DSHB). Secondary conjugated antibodies (Jackson) used were Cy3 anti-rabbit (1:1000), Cy5 antimouse (1:250), and HRP anti-rabbit (1:1000).
